Outcomes in patients with chronic kidney disease not on dialysis receiving extended dosing regimens of darbepoetin alfa: long-term results of the EXTEND observational cohort study

BACKGROUND: Extended dosing of the erythropoiesis-stimulating agent (ESA) darbepoetin alfa (DA) once biweekly or monthly reduces anaemia treatment burden. This observational study assessed outcomes and dosing patterns in patients with chronic kidney disease not on dialysis (CKD-NoD) commencing exten...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Nephrol Dial Transplant
Egile Nagusiak: Galle, Jan-Christoph, Addison, Janet, Suranyi, Michael G., Claes, Kathleen, Di Giulio, Salvatore, Guerin, Alain, Herlitz, Hans, Kiss, István, Farouk, Mourad, Manamley, Nick, Wirnsberger, Gerhard, Winearls, Christopher
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2016
Gaiak:
CLINICAL SCIENCE
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5146706/
https://ncbi.nlm.nih.gov/pubmed/27190334
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfw047
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak